My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 477

    1.

    Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.

    Lu J, Guo Z, Pan X, Wang G, Zhang D, Li Y, Tan B, Ouyang L, Yu X.

    Respir Res. 2006 Mar 23;7:43.PMID: 16553963 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.

    Wang X, Ni B, Du X, Zhao G, Gao W, Shi X, Zhang S, Zhang L, Wang D, Luo D, Xing L, Jiang H, Li W, Jiang M, Mao L, He Y, Xiao Y, Wu Y.

    Antivir Ther. 2005;10(5):681-90.PMID: 16152762 [PubMed - indexed for MEDLINE]Related articles

    3.

    Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

    Virology. 2008 Oct 25;380(2):412-20. Epub 2008 Sep 10.PMID: 18786689 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments.

    Ramisse F, Deramoudt FX, Szatanik M, Bianchi A, Binder P, Hannoun C, Alonso JM.

    Clin Exp Immunol. 1998 Mar;111(3):583-7.PMID: 9528903 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.

    Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z.

    BMC Infect Dis. 2009 Feb 12;9:17.PMID: 19216752 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

    Sawai T, Itoh Y, Ozaki H, Isoda N, Okamoto K, Kashima Y, Kawaoka Y, Takeuchi Y, Kida H, Ogasawara K.

    Immunology. 2008 Jun;124(2):155-65. Epub 2008 Jan 16.PMID: 18205793 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.

    Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.

    Vaccine. 2008 Jan 24;26(4):562-72. Epub 2007 Dec 3.PMID: 18164788 [PubMed - indexed for MEDLINE]Related articles

    8.

    Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.

    Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z.

    Viral Immunol. 2009 Jul;22(4):273-81.PMID: 19594398 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study]

    Kishimoto C, Hiraoka Y, Takada H, Kurokawa M, Ochiai H.

    J Cardiol. 2005 Jun;45(6):247-55. Japanese. PMID: 15991608 [PubMed - indexed for MEDLINE]Related articles

    10.

    Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

    Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, Stephenson I, Bright RA, Katz JM, Mittal SK, Sambhara S.

    Lancet. 2006 Feb 11;367(9509):475-81.PMID: 16473124 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets.

    Song MS, Oh TK, Pascua PN, Moon HJ, Lee JH, Baek YH, Woo KJ, Yoon Y, Sung MH, Poo H, Kim CJ, Choi YK.

    Vaccine. 2009 May 21;27(24):3145-52. Epub 2009 Apr 9.PMID: 19446184 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

    Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Takahashi H, Sawa H, Mitchell WM, Strayer DR, Carter WA, Chiba J, Kurata T, Sata T, Hasegawa H.

    J Infect Dis. 2007 Nov 1;196(9):1313-20. Epub 2007 Oct 5.PMID: 17922395 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.

    Kashima Y, Ikeda M, Itoh Y, Sakoda Y, Nagata T, Miyake T, Soda K, Ozaki H, Nakayama M, Shibuya H, Okamatsu M, Ishigaki H, Ishida H, Sawai T, Kawaoka Y, Kida H, Ogasawara K.

    Vaccine. 2009 Dec 9;27(52):7402-8. Epub 2009 Sep 10.PMID: 19747993 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

    Simmons CP, Bernasconi NL, Suguitan AL, Mills K, Ward JM, Chau NV, Hien TT, Sallusto F, Ha do Q, Farrar J, de Jong MD, Lanzavecchia A, Subbarao K.

    PLoS Med. 2007 May;4(5):e178.PMID: 17535101 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.

    Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, Belser JA, Hancock K, Shu Y, Katz JM, Liang M, Li D.

    PLoS One. 2009;4(5):e5476. Epub 2009 May 7.PMID: 19421326 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

    Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM.

    J Virol. 2009 Jun;83(11):5726-34. Epub 2009 Mar 25.PMID: 19321609 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

    Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

    Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.PMID: 17050041 [PubMed - indexed for MEDLINE]Related articles

    18.

    Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

    Crevar CJ, Ross TM.

    Virol J. 2008 Oct 28;5:131.PMID: 18957098 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

    Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

    Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.PMID: 17870216 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

    Mayrhofer J, Coulibaly S, Hessel A, Holzer GW, Schwendinger M, Brühl P, Gerencer M, Crowe BA, Shuo S, Hong W, Tan YJ, Dietrich B, Sabarth N, Savidis-Dacho H, Kistner O, Barrett PN, Falkner FG.

    J Virol. 2009 May;83(10):5192-203. Epub 2009 Mar 11.PMID: 19279103 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk